Check out our most popular compounded medications! Get Started
Dexamethasone 4 mg/mL Solution for Iontophoresis is a specialized liquid formulation designed for use in iontophoresis therapy. This method utilizes an electric current to enhance the transdermal delivery of dexamethasone through the skin, providing targeted treatment.
This formulation is primarily used to treat inflammatory conditions, including tendinitis, bursitis, and arthritis, as well as to manage localized pain and edema.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Dexamethasone 4 mg/mL Solution for Iontophoresis is a specialized liquid formulation designed to deliver the potent anti-inflammatory effects of dexamethasone directly through the skin using iontophoresis therapy. By applying a mild electric current, this method facilitates the transdermal passage of the medication, ensuring targeted treatment to the affected area with minimal systemic absorption.
This formulation is particularly beneficial for patients experiencing localized inflammatory conditions such as tendinitis, bursitis, epicondylitis (tennis elbow), plantar fasciitis, osteoarthritis, and various soft tissue injuries. By concentrating the therapeutic effects of dexamethasone at the site of inflammation, it helps reduce pain, swelling, and promotes healing without the need for oral steroids, thereby minimizing potential systemic side effects.
It provides the advantage of delivering a controlled dose of dexamethasone directly to the site of inflammation. This can lead to improved patient outcomes, especially in cases where oral administration is contraindicated or not well-tolerated.
Patients undergoing iontophoresis with Dexamethasone 4 mg/mL Solution can expect a non-invasive and painless procedure. The treatment involves placing electrodes on the skin, through which a gentle electrical current is passed to drive the medication into the underlying tissues. Some patients may experience a slight tingling sensation during the procedure, but it is generally well-tolerated. This method allows for focused therapy with reduced risk of systemic side effects commonly associated with corticosteroids.
As with any medical treatment, it is essential to consider potential side effects and contraindications. Skin irritation at the site of electrode placement is possible, and patients with known hypersensitivity to dexamethasone or corticosteroids should not use this formulation. Additionally, iontophoresis is contraindicated in patients with implanted electronic devices (such as pacemakers) and in areas with broken or compromised skin.
If you have any questions about Dexamethasone 4 mg/mL Solution for Iontophoresis or its suitability for your specific condition, please reach out to us. Our team of compounding pharmacists at Bayview Pharmacy is here to provide you with comprehensive information and support for your therapeutic needs.
Dexamethasone 4 mg/mL Solution for Iontophoresis is a specialized formulation designed to deliver dexamethasone, a potent corticosteroid, directly through the skin using an electric current. This method is particularly beneficial for localized treatment, offering targeted relief for conditions such as inflammation, pain, and other localized issues. However, like all medications, it is important to consider potential drug interactions that may affect the efficacy and safety of the treatment.
Patients and prescribers should be aware that dexamethasone, being a corticosteroid, can interact with a variety of medications. One of the primary concerns is the potential for systemic absorption, even though iontophoresis is designed for localized delivery. Systemic absorption, although minimal, can lead to interactions similar to those seen with oral or injectable corticosteroids.
Concomitant use of dexamethasone with nonsteroidal anti-inflammatory drugs (NSAIDs) may increase the risk of gastrointestinal ulceration or bleeding. Patients should be monitored for signs of gastrointestinal distress, and prescribers may consider gastroprotective agents if long-term use is necessary.
When used with anticoagulants such as warfarin, dexamethasone may alter the effects of these medications, potentially leading to an increased risk of bleeding. Regular monitoring of coagulation parameters is advised to ensure therapeutic levels are maintained without adverse effects.
Dexamethasone may also interact with certain antidiabetic medications, potentially leading to altered blood glucose levels. Patients with diabetes should closely monitor their blood sugar levels and consult with their healthcare provider to adjust their antidiabetic regimen as needed.
Additionally, the use of dexamethasone with other immunosuppressive agents can increase the risk of infections due to additive immunosuppressive effects. Patients should be advised to report any signs of infection promptly, and prescribers should consider the patient's overall immunosuppressive burden when prescribing this therapy.
Patients taking medications that induce or inhibit cytochrome P450 enzymes, particularly CYP3A4, should be aware that these can affect the metabolism of dexamethasone, potentially altering its efficacy and safety profile. Prescribers should review the patient's medication list for potential CYP3A4 interactions and adjust the treatment plan accordingly.
It is crucial for both patients and prescribers to maintain open communication regarding all medications being taken, including over-the-counter drugs and supplements, to ensure safe and appropriate use of Dexamethasone 4 mg/mL Solution for Iontophoresis. If you have any questions or concerns about potential drug interactions, please reach out to us at Bayview Pharmacy for further guidance and support.
Dexamethasone 4 mg/mL Solution for Iontophoresis is a specialized liquid formulation designed to enhance the delivery of dexamethasone, a potent corticosteroid, through the skin using iontophoresis therapy. Iontophoresis is a non-invasive technique that employs a mild electric current to drive charged molecules of medication across the skin barrier, allowing for localized treatment. This method is particularly beneficial for conditions requiring targeted drug delivery, such as inflammation, pain management, and other localized conditions where systemic administration might not be as effective or could lead to unwanted side effects.
The mechanism of action for dexamethasone in this formulation involves its anti-inflammatory and immunosuppressive properties. Dexamethasone works by inhibiting the release of substances in the body that cause inflammation, thereby reducing swelling, redness, and pain in the affected area. When used in iontophoresis, the electric current facilitates the movement of dexamethasone ions into the deeper layers of the skin, allowing for a higher concentration of the drug to reach the target tissue.
For patients, this means that dexamethasone iontophoresis can provide relief from symptoms associated with conditions such as tendonitis, bursitis, and other musculoskeletal disorders. The treatment is typically painless, and the sensation of the electric current is often described as a mild tingling. The procedure is usually performed in a clinical setting by a healthcare professional, ensuring proper application and monitoring. Patients may require multiple sessions depending on the severity of their condition and the response to treatment.
For prescribers, dexamethasone 4 mg/mL Solution for Iontophoresis offers a targeted therapeutic option that can be integrated into a comprehensive treatment plan for patients with localized inflammatory conditions. It is important to assess the patient's overall health, the specific condition being treated, and any potential contraindications or interactions with other medications the patient may be taking. Prescribers should also consider the frequency and duration of iontophoresis sessions to optimize therapeutic outcomes while minimizing the risk of adverse effects.
If you have any questions about this formulation or its use in iontophoresis therapy, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide you with the information and support you need to make informed decisions about your treatment options.
Dexamethasone 4 mg/mL Solution for Iontophoresis is a specialized liquid formulation used in iontophoresis therapy. It involves the application of an electric current to facilitate the transdermal delivery of dexamethasone through the skin, providing targeted treatment for conditions such as pain management or localized drug delivery.
Iontophoresis works by using a mild electric current to drive the dexamethasone solution through the skin. This process enhances the absorption of the medication directly into the affected area.
This formulation is commonly used for pain management and to treat localized inflammatory conditions.
When used as directed by a healthcare professional, Dexamethasone 4 mg/mL Solution for Iontophoresis is generally considered safe. However, it is important to follow the prescribed guidelines and consult with a healthcare provider to ensure it is appropriate for your specific condition.
The solution is applied to the skin over the area requiring treatment. An electrode is then placed over the solution, and a mild electric current is passed through it, facilitating the delivery of the medication into the skin.
Some patients may experience mild skin irritation or redness at the site of application. If you experience any severe reactions or persistent discomfort, it is important to contact your healthcare provider.
A typical iontophoresis session using Dexamethasone 4 mg/mL Solution usually lasts between 10 to 20 minutes, depending on the specific treatment protocol recommended by your healthcare provider.
While iontophoresis devices are available for home use, it is crucial to receive proper training and instructions from a healthcare professional to ensure appropriate treatment. Always consult with your healthcare provider before starting home treatments.
The frequency of iontophoresis sessions will depend on the condition being treated and the recommendation of your healthcare provider. Typically, treatments may be scheduled several times a week until the desired therapeutic effect is achieved.
Individuals with certain medical conditions, such as skin infections at the treatment site, or those with pacemakers or other electronic implants, should avoid iontophoresis. Always consult with a healthcare provider to determine if this treatment is suitable for you.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)
